Early access
Sign in
Taking people in RomaniaPhase 1

First test of NBIM-1008 in adults with rheumatoid arthritis

Tests the safety of the new medicine NBIM-1008 in adults with rheumatoid arthritis.

Key facts

Who runs it
Neurocrine Biosciences Inc.
Where
Bucharest and Cluj-Napoca, RomaniaSee the 2 sitesAlso in 1 other country, 1 site
Registry title
A First-in-Human, Open-label, Phase 1 Study to Evaluate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy of NBIM-1008 in Patients with Rheumatoid Arthritis
Status
Recruiting
Phase
Phase 1
People taking part
15 people, planned
Started
10 Jun 2026
Expected to end
11 Sept 2028
Type of study
Interventional
Record updated
10 August 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with rheumatoid arthritis to test the safety and early effect of a new treatment, NBIM-1008, in humans for the first time.

Age
18 to 64 years
Sex
All sexes can join.

Check if you might fit

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 64 years old?

Where in Romania

Also in 1 other country, 1 site

  • Arensia Clinics S.R.L.Bucharest, RomaniaTaking people
  • Spitalul Clinic Judetean De Urgenta ClujCluj-Napoca, RomaniaTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record

Print a page for my doctor

Data and sources

Registry record
Listed on the EU's official list of trials (CTIS).
Plain-language title
First test of NBIM-1008 in adults with rheumatoid arthritisGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 9 November 2026.
Fit questions
Built from 2025-525113-22-00, who can take part
Record updated
10 August 2026